| Typicality: | 0.250 |
| Saliency: | 0.000 |
| of europe | 3 | location |
| as a medical drug | 3 | manner |
| glucosamine → be approved in → most of europe | 3 |
| negative | neutral | positive |
| 0.034 | 0.742 | 0.225 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 79.752 |